Navigation Links
Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer

IRVING, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Reata Pharmaceuticals, Inc. today announced the publication of a review article covering the company's Synthetic Triterpenoid programs in the May 2007 issue of the prestigious journal "Nature Reviews Cancer."

The article, "Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer," by researchers and Reata scientific collaborators from the Dartmouth Medical School Karen T. Liby, Mark M. Yore and Michael B. Sporn, focuses on two new classes of multifunctional drugs that it reports can prevent and treat cancer in experimental animals. One of Reata's lead clinical candidates, from one of the classes the article describes, the Synthetic Triterpenoids, is entering advanced clinical trials for deadly, late-stage cancers.

The article describes the Synthetic Triterpenoids as a new class of non-toxic and highly multifunctional drugs that have applications for the prevention and treatment of not only cancer, but also of many other diseases with an inflammatory component.

"An outstanding body of work is emerging on the Synthetic Triterpenoids from many top academic collaborators," commented Warren Huff, Reata's CEO. "Dr. Sporn and his team have provided an excellent summary of the broad research currently underway on these compounds and the underlying biological pathways they modulate. Reata is delighted to have the opportunity to collaborate with these researchers in taking take these important new drugs forward to provide a clinical benefit for patients with cancer and other diseases."

Reata in-licensed the complete series of Synthetic Triterpenoids from Dartmouth and the University of Texas M.D. Anderson Cancer Center in 2004. RTA 402, the lead agent from this series, has recently begun Phase 2 clinical studies for cancer and anti-inflammatory diseases. An ongoing Phase 1 study in cancer patients has demonstrated
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
8. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reata Synthetic Triterpenoids Profiled Nature Reviews Cancer
(Date:11/29/2009)...CHICAGO, Nov. 30 Elastography is a... to breast ultrasound, helps distinguish cancerous...an ongoing study presented today at the annual mee...(RSNA). ,, When mammography yields suspicious f... additional information. However, ultrasound has t...
(Date:11/29/2009)..., IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /PRNewsw...uantitative imaging software for the advanced anal...nologies, a leader in minimally invasive delivery ...e companies have signed a definitive agreement cov...obronchial lung navigation and biopsy system. ,...
(Date:11/29/2009)...CHICAGO, Nov. 29 Researchers using...tudy brain activation have found that men and wome...muli, according to a study presented today at the ...h America (RSNA). ,, "Men may direct more atten...end to process them in terms of implications for r...
Breaking Medicine Technology:Elastography Reduces Unnecessary Breast Biopsies 2Elastography Reduces Unnecessary Breast Biopsies 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 1BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 2Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 1Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 2Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 3OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 1OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 2OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 3OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 4OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 5
...Form of a GLP1-analog Aimed at Improving Glyc...SALEM, Israel, September 16 Oramed,Pharmaceutical... delivery,systems, announced today that it has lau...log., ORMD 0901 belongs to the Incretin family of...eduction in blood glucose levels and inhibiting,gl...
... France, Sept. 16, DSM and LibraGen, a bacterial d...nnounced today that they have signed an agreement ...on of chiral amines. Under,the terms of the partne...scovery and development to identify new enzymes fo...ns into optically pure R- and S-amines, a,compound...
Other Medicine Technology:Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines 2DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines 3
(Date:11/30/2009)...treating a tumor without disturbing normal tissue ...therapies can be invasive and harsh. , Researche...a way they might deliver the right therapy directl...rs, which specifically bind to living tumor tissue...rodent with liver cancer until they found the best...
(Date:11/30/2009)...owMyPC has released an online service that lets us...e. This is the first hosted service in the world t...rogram. Result, blazing fast performance even over...nta Clara, CA (PRWEB) November 30, 2009 -- ShowMyP...ess Service that uses the familiar Microsoft Remot...
(Date:11/30/2009)... best serve our patients, their caregivers, and ou...itute of Women,s Health of North America in Florid... service is available to all individuals (male and...te to locate a convenient LOCATION near you or c...cus) November 30, 2009 -- According to the most re...
(Date:11/30/2009)...wyers from The Healy Law Firm secure the highest p... of man rendered an incomplete quadriplegic. , ...vember 30, 2009 -- A Cook County jury has entered ...rant carpenter, 22 years old at the time, who dove...te quadriplegic. The verdict, which was reduced t...
(Date:11/30/2009)...oking is on the rise in the developing world but f...mitment to stop smoking cigarette, but the recent ...actually help people quit smoking cigarette. htt...gnated to help heavy smokers cut down on their cig... Los Angeles, CA (PRWEB) November 30, 200...
Breaking Medicine News(10 mins):Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 3Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Stop Smoking Cigarette with Electronic Cigarette (E-Cig), Today You Can Quit Smoking Too 2
...University of Illinois at Chicago researchers have...tion and achieved insulin independence in diabetes...atic islet cells. , The study results are publish...istent insulin independence in severe type 1 diabe...
... STANFORD, Calif. - A single dose of antibiotics ...g that occurs in vaginal tissues during many birth...dren,s Hospital at Stanford, the Stanford Universi...nd long-term repercussions of this relatively comm...
...SO 9001:2000 certification recognizes ISI,s CA and...bmission processes excellence, - Certifications bu...hina, - ISI plans to seek certification for Europ...ng software and services to streamline the drug,de...
...pany donates $100,000 to American Red Cross, INDI..., the charitable arm of Eli Lilly and Company (NYS...00,000 in financial assistance to aid,Indiana torn...nd severe storms. This weekend, an estimated 10,00...
...LMSFORD, Mass., June 9 ESA Biosciences, a Magella...ems to screen children for,lead poisoning, announc...vice president of sales and marketing for ESA,s cl...for LabCorp,s,esoteric business. Previously, he wa...
... Most Concrete Legislation in America to Protect L...ver 30 Years, OKLAHOMA CITY, June 9 The Sex Offe...ts kind in the nation and the most concrete,legisl...day, June 10 at 11 am CDT in the Oklahoma State Ca...
Other Medicine News:Health News:Promising advances in islet cell transplants for diabetes 2Health News:Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds 2Health News:ISI Receives New ISO 9001:2000 Certifications in California and New Jersey 2Health News:ISI Receives New ISO 9001:2000 Certifications in California and New Jersey 3Health News:Lilly to Provide Aid to Indiana Tornado and Flood Victims 2Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 2Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 3Health News:Nursing Home for Sex Offenders Becomes Law, a First in America 2
BET/1P-ERB - Tubular Base - Model 1P63
BET/1P-ERB - Tubular Base - Model 1P61-ERB
BET/1P-ERB - Tubular Base - Model 1P42-ERB
BET/1P-ERB - Tubular Base - Model 1P42-R-ERB
Medicine Products: